haloperidol has been researched along with Pituitary Neoplasms in 25 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of cyproheptadine on growth hormone (GH) and prolactin (Prl) secretion from cultured pituitary adenoma cells of acromegaly and pituitary gigantism was studied." | 7.67 | Cyproheptadine-mediated inhibition of growth hormone and prolactin release from pituitary adenoma cells of acromegaly and gigantism in culture. ( Fukushima, T; Ishibashi, M; Yamaji, T, 1985) |
| "Both normal pituitary fragments and pituitary adenomatous cells (from all types of adenomas studied) spontaneously released TRH in vitro." | 5.28 | Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin. ( Barret, A; Brandi, AM; Feinstein, MC; Le Dafniet, M; Lefebvre, P; Mechain, C; Peillon, F, 1990) |
| " Risperidone had the highest adjusted reporting ratios for hyperprolactinemia (EBGM 34." | 3.73 | Atypical antipsychotics and pituitary tumors: a pharmacovigilance study. ( Doraiswamy, PM; Levine, JG; Szarfman, A; Tonning, JM, 2006) |
| "The effect of cyproheptadine on growth hormone (GH) and prolactin (Prl) secretion from cultured pituitary adenoma cells of acromegaly and pituitary gigantism was studied." | 3.67 | Cyproheptadine-mediated inhibition of growth hormone and prolactin release from pituitary adenoma cells of acromegaly and gigantism in culture. ( Fukushima, T; Ishibashi, M; Yamaji, T, 1985) |
| "Both normal pituitary fragments and pituitary adenomatous cells (from all types of adenomas studied) spontaneously released TRH in vitro." | 1.28 | Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin. ( Barret, A; Brandi, AM; Feinstein, MC; Le Dafniet, M; Lefebvre, P; Mechain, C; Peillon, F, 1990) |
| "Treatment with bromocriptine further diminished the anterior lobe PRL content, whereas haloperidol partially inhibited this tumor-mediated diminution." | 1.27 | Hyperprolactinemia exerts a negative effect on the beta-endorphin content of the rat neurointermediate pituitary lobe. ( Bons, EG; Hackeng, WH; Lamberts, SW; Oosterom, R; Uitterlinden, P; Verleun, T; Zuiderwijk, JM, 1984) |
| "An ectopic ACTH secreting lung carcinoid was non-responsive to doses of bromocriptine up to 13 microM." | 1.26 | Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism. ( Adams, EF; Ashby, MJ; Brown, SM; Mashiter, K; White, MC, 1981) |
| "Rats treated with haloperidol or bearing subcutaneous implants of prolactin-secreting tumors had elevated CSF prolactin levels compared to those observed in control rats." | 1.26 | Prolactin in human and rat serum and cerebrospinal fluid. ( Login, IS; MacLeod, RM, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (68.00) | 18.7374 |
| 1990's | 4 (16.00) | 18.2507 |
| 2000's | 2 (8.00) | 29.6817 |
| 2010's | 2 (8.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lertxundi, U | 1 |
| Erezuma, I | 1 |
| Hernandez, R | 1 |
| Medrano, J | 1 |
| Garcia, M | 1 |
| Aguirre, C | 1 |
| Madhusoodanan, S | 1 |
| Steinberg, LR | 1 |
| Coleman, A | 1 |
| Bavli, S | 1 |
| Szarfman, A | 1 |
| Tonning, JM | 1 |
| Levine, JG | 1 |
| Doraiswamy, PM | 1 |
| Konopelska, S | 1 |
| Quinkler, M | 1 |
| Strasburger, CJ | 1 |
| Ventz, M | 1 |
| Ishibashi, M | 3 |
| Yamaji, T | 3 |
| Adams, EF | 1 |
| Ashby, MJ | 1 |
| Brown, SM | 1 |
| White, MC | 1 |
| Mashiter, K | 1 |
| Lamberts, SW | 3 |
| Uitterlinden, P | 1 |
| Bons, EG | 1 |
| Zuiderwijk, JM | 1 |
| Verleun, T | 1 |
| Oosterom, R | 1 |
| Hackeng, WH | 1 |
| de Quijada, M | 1 |
| Timmermans, HA | 1 |
| MacLeod, RM | 7 |
| Canonico, PL | 1 |
| Valdenegro, CA | 1 |
| Login, IS | 3 |
| Nagy, I | 1 |
| Florio, T | 1 |
| Pan, MG | 1 |
| Newman, B | 1 |
| Hershberger, RE | 1 |
| Civelli, O | 1 |
| Stork, PJ | 1 |
| Scholten-Sloof, BE | 1 |
| Knol, BW | 1 |
| Rijnberk, A | 1 |
| Mol, JA | 1 |
| Middleton, DJ | 1 |
| Ubbink, GJ | 1 |
| Lew, JY | 1 |
| Zawadzka, H | 1 |
| Feigenblum, D | 1 |
| Tang, D | 1 |
| Filer, D | 1 |
| Benedetto, P | 1 |
| Goldstein, M | 1 |
| Le Dafniet, M | 1 |
| Lefebvre, P | 1 |
| Barret, A | 1 |
| Mechain, C | 1 |
| Feinstein, MC | 1 |
| Brandi, AM | 1 |
| Peillon, F | 1 |
| Judd, AM | 1 |
| Kovacs, K | 1 |
| Ross, PC | 1 |
| Spangelo, BL | 1 |
| Jarvis, WD | 1 |
| Teramoto, A | 1 |
| Fukushima, T | 2 |
| Shukla, S | 1 |
| Turner, WJ | 1 |
| Newman, G | 1 |
| Israel, JM | 1 |
| Jaquet, P | 1 |
| Vincent, JD | 1 |
| Takeda, M | 1 |
| Tanino, S | 1 |
| Nishinuma, K | 1 |
| Matsubayashi, T | 1 |
| Yamashita, S | 1 |
| Nishimura, T | 1 |
| Lehmeyer, JE | 1 |
| McLachlan, MS | 2 |
| Lavender, JP | 1 |
| Edwards, CR | 1 |
2 reviews available for haloperidol and Pituitary Neoplasms
| Article | Year |
|---|---|
Hyperprolactinemia Secondary to Pituitary Microadenoma Versus Haloperidol- A Diagnostic Enigma. A Case Report and Brief Review.
Topics: Adenoma; Antipsychotic Agents; Diagnosis, Differential; Haloperidol; Humans; Hyperprolactinemia; Mal | 2017 |
Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dopamine Agonists; Dopamine Antagonists; Drug | 2008 |
23 other studies available for haloperidol and Pituitary Neoplasms
| Article | Year |
|---|---|
Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance).
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Child; Databases, Factual; Female; Halop | 2019 |
Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Amenorrhea; Antipsychotic Agents; Aripiprazole; | 2006 |
Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Cells, Cultured; Dopamine; Endorphins; Female; Growth Hor | 1984 |
Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Bromocriptine; Carcinoid Tumor; Cells, Cultured; Dopami | 1981 |
Hyperprolactinemia exerts a negative effect on the beta-endorphin content of the rat neurointermediate pituitary lobe.
Topics: Adrenocorticotropic Hormone; Animals; beta-Endorphin; beta-Lipotropin; Bromocriptine; Cell Line; End | 1984 |
Tamoxifen enhances the sensitivity of dispersed prolactin-secreting pituitary tumor cells to dopamine and bromocriptine.
Topics: Animals; Bromocriptine; Dopamine; Estradiol; Female; Haloperidol; Neoplasms, Experimental; Pituitary | 1980 |
The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
Topics: Animals; Bromocriptine; Dopamine; Female; Haloperidol; Male; Phosphates; Phosphatidylinositols; Pimo | 1983 |
Restoration of pituitary prolactin synthesis and release by the administration of morphine to rats bearing a transplanted prolactin-secreting tumor.
Topics: Animals; Female; Haloperidol; Morphine; Neoplasms, Experimental; Pituitary Gland, Anterior; Pituitar | 1981 |
Effects of cyproheptadine on prolactin synthesis and release by normal and suppressed pituitary glands and by dispersed pituitary tumor cells.
Topics: Animals; Cyproheptadine; Female; Haloperidol; Male; Methysergide; Perphenazine; Pimozide; Pituitary | 1978 |
Prolactin in human and rat serum and cerebrospinal fluid.
Topics: Adenoma; Animals; Female; Haloperidol; Humans; Neoplasm Transplantation; Pituitary Neoplasms; Prolac | 1977 |
Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity.
Topics: Adenylyl Cyclases; Animals; Biological Transport; DNA Replication; DNA, Neoplasm; Dopamine; Haloperi | 1992 |
Pituitary-dependent hyperadrenocorticism in a family of Dandie Dinmont terriers.
Topics: Adenocarcinoma; Adrenal Cortex; Adrenal Cortex Diseases; Animals; Corticotropin-Releasing Hormone; D | 1992 |
Regulation and molecular characterization of dopamine D2 receptors in a prolactin-secreting 7315a anterior pituitary tumor.
Topics: Animals; Azides; Blotting, Northern; Butaclamol; Corpus Striatum; Female; Haloperidol; In Vitro Tech | 1990 |
Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin.
Topics: Adenoma; Chromatography, High Pressure Liquid; Dopamine; Female; Haloperidol; Humans; In Vitro Techn | 1990 |
Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine.
Topics: Calcium; Cholera Toxin; Colforsin; Cyclic AMP; Dopamine; Enzyme Activation; Estradiol; Haloperidol; | 1988 |
Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Cells, Cultured; Corticotropin-Releasing Hormone; Cushi | 1985 |
Cyproheptadine-mediated inhibition of growth hormone and prolactin release from pituitary adenoma cells of acromegaly and gigantism in culture.
Topics: Acromegaly; Adenoma, Acidophil; Adenoma, Chromophobe; Adult; Cells, Cultured; Child; Cyproheptadine; | 1985 |
Bromocriptine-related psychosis and treatment.
Topics: Adult; Bromocriptine; Female; Haloperidol; Humans; Pituitary Neoplasms; Prolactin; Psychoses, Substa | 1985 |
The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine.
Topics: Adenoma; Bromocriptine; Domperidone; Dopamine; Dose-Response Relationship, Drug; Electrophysiology; | 1985 |
A case of hypophyseal prolactinoma with treatable delusions of dermatozoiasis.
Topics: Aged; Bromocriptine; Delusions; Female; Haloperidol; Humans; Hypochondriasis; Insecta; Pituitary Neo | 1985 |
Restoration of prolactin synthesis and release by the administration of monoaminergic blocking agents to pituitary tumor-bearing rats.
Topics: Animals; Dopamine; Dopamine Antagonists; Female; Haloperidol; In Vitro Techniques; Leucine; Male; Ne | 1974 |
Polytome encephalography in investigation of pituitary tumours.
Topics: Analgesics; Cerebral Ventriculography; Haloperidol; Humans; Isonipecotic Acids; Phenoperidine; Pitui | 1970 |
Polytome-encephalography in the investigation of pituitary tumours.
Topics: Acromegaly; Adenoma, Chromophobe; Adolescent; Adult; Aged; Cerebral Ventriculography; Craniopharyngi | 1971 |